NASDAQ
No price data available for this timeframe.
Iovance Biotherapeutics, Inc. (IOVA) has a current ratio of 3.20x as of Monday, May 25, 2026. This represents a 26.69% decrease compared to its 12-month average of 4.36x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.